ArticleEpidemiology and infection2024
Macrolide resistance of
Abstract read
In one paragraph
Article in Epidemiology and infection, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Prevalence, risk factors, and early prediction of refractory pneumonia caused by Mycoplasma pneumoniae in children: a systematic review and meta-analysis.European journal of pediatrics · 2026Pooled it
- Association between point mutations of macrolide-resistantFrontiers in pharmacology · 2025Pooled it
- Reporting macrolide-resistantJournal of clinical microbiology · 2026Review
- Genomic Surveillance Reveals Emergence and Spread of Macrolide-Resistant Mycoplasma pneumoniae in Australia During the 2023-2024 Epidemic.The Journal of infectious diseases · 2026Article
- A2063G macrolide-resistant Mycoplasma pneumoniae: epidemic dominance without more frequent pulmonary consolidation or worse short-term in-hospital outcomes in hospitalized children.BMC pediatrics · 2026Article
- East Asia as a sentinel: risk-stratified corticosteroid therapy for paediatric macrolide-resistantEuropean respiratory review : an official journal of the European Respiratory Society · 2026Review
- Routine admission biomarkers for identifying co-infection and stratifying severity in pediatric macrolide-resistantTranslational pediatrics · 2026Article
- Clinical application and safety observation of levofloxacin in children with refractory Mycoplasma pneumoniae pneumonia.BMC infectious diseases · 2026Article
- Beyond Ribosomal Mutations: Identification ofMicroorganisms · 2026Article
- Antimicrobial Susceptibility and Distribution Characteristics ofPharmaceuticals (Basel, Switzerland) · 2026Article
- Article
- Clinical Characteristics, Treatment and Long-Term Prognosis ofInfection and drug resistance · 2026Article
- Analysis of Clinical Characteristics and Risk Factors of Pediatric Macrolide-ResistantInfection and drug resistance · 2026Article
- Doxycycline for Macrolide-ResistantInfection and drug resistance · 2026Review
- Comprehensive study of community acquiredWorld journal of clinical pediatrics · 2025Article
- Characterizing the epidemiology ofEmerging microbes & infections · 2025Article
- Clinical characteristics and outcomes of macrolide-resistantTranslational pediatrics · 2025Article
- Clinical features of MPP with or without viruses among hospitalized children in 2023, Wenzhou, Zhejiang, China.Italian journal of pediatrics · 2025Article
- Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities.Current opinion in infectious diseases · 2025Review
- Clinical score for early escalation in pediatric A2063G Mycoplasma pneumoniae pneumonia: a retrospective cohort study.BMC infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors.
Yue JiangBeijing Chaoyang Hospital,Capital Medical University, Beijing, China.ORCID 0000-0003-2770-0579
Haiwei DouTropical Medicine Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing, China.ORCID 0009-0002-7229-4995
Bo XuBeijing Friendship Hospital, Capital Medical University, Beijing, China.
Baoping XuBeijing Children's Hospital, Capital Medical University, China National Clinical Research Center of Respiratory Diseases, National Center for Children's Health, Beijing, China.
Wei ZhouPeking University Third Hospital, Beijing, China.
Hong WangCivil Aviation General Hospital, Beijing, China.
Lixia GeChina Meitan General Hospital, Beijing, China.
Yinghui HuNew Century International hospital for Children, Beijing, China.
Xiaohua HanShengjing Hospital of China Medical University, Shenyang, China.
Xuanguang QinBeijing Chaoyang Hospital,Capital Medical University, Beijing, China.
Jing LiBeijing Changping District Integrated Traditional Chinese and Western Medicine Hospital, Beijing, China.
Leping YePeking University First Hospital, Beijing, China.
Liqun WuDongfang Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China.
Huimin ZuoThe First Hospital of Tsinghua University, Beijing, China.
Qi ZhangChina-Japan Friendship Hospital, Beijing, China.
Ling LiuPeking University Third Hospital, Beijing, China.
Wenjuan HuCivil Aviation General Hospital, Beijing, China.
Junyan ShaoChina Meitan General Hospital, Beijing, China.
Qiaomian YinNew Century International hospital for Children, Beijing, China.
Lina HanShengjing Hospital of China Medical University, Shenyang, China.
Xiaoyan FuBeijing Chaoyang Hospital,Capital Medical University, Beijing, China.
Xiaopei DongBeijing Chaoyang Hospital,Capital Medical University, Beijing, China.
Yan DongBeijing Changping District Integrated Traditional Chinese and Western Medicine Hospital, Beijing, China.
Yulin FuBeijing Changping District Integrated Traditional Chinese and Western Medicine Hospital, Beijing, China.
Mengmeng ZhaoPeking University First Hospital, Beijing, China.
Qing SunPeking University First Hospital, Beijing, China.
Jingwei HuoDongfang Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China.
Die LiuChina-Japan Friendship Hospital, Beijing, China.
Wenkao LiuBeijing Changping District Integrated Traditional Chinese and Western Medicine Hospital, Beijing, China.
Yunjuan LiNew Century International hospital for Children, Beijing, China.
Yang WangNew Century International hospital for Children, Beijing, China.
Deli XinTropical Medicine Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Kunling ShenBeijing Children's Hospital, Capital Medical University, China National Clinical Research Center of Respiratory Diseases, National Center for Children's Health, Beijing, China.
Funding
National Natural Science Foundation of China 81271890
Abstract
This paper retrospectively analysed the prevalence of macrolide-resistant
Indexed as
Anti-Bacterial AgentsDrug Resistance, BacterialMacrolidesMycoplasma pneumoniaePneumonia, MycoplasmaAdolescentAdultAgedAged, 80 and overChildChild, PreschoolChinaFemaleHumansInfantMaleAnti-Bacterial AgentsMacrolidesRNA, Ribosomal, 23Sclinical featuresdrug-resistantepidemicmacrolideMycoplasma pneumoniae
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.